Evidence map›Paper›PMID 40753407›Full record

Trial reportBMC geriatrics2025

Tailored interventions for inappropriate psychotropic drug use in nursing home residents with dementia: participatory action research in a special case of a stepped-wedge cluster randomized controlled trial.

Claudia M Groot Kormelinck, Debby L Gerritsen, Charlotte F van Teunenbroek, Michiel R de Boer, Martin Smalbrugge, Sytse U Zuidema

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claudia M Groot KormelinckDepartment of Primary and Long-term Care, University of Groningen, University Medical Centre Groningen, PO Box 196, Groningen, 9700 AD, FA21, the Netherlands. c.m.groot.kormelinck@umcg.nl.ORCID http://orcid.org/0000-0002-4680-0738
Debby L GerritsenDepartment of Primary and Community Care, Radboud UMC Alzheimer Centre, Research Institute for Medical Innovation, Radboud University Medical Centre, Nijmegen, the Netherlands.
Charlotte F van TeunenbroekDepartment of Primary and Long-term Care, University of Groningen, University Medical Centre Groningen, PO Box 196, Groningen, 9700 AD, FA21, the Netherlands.
Michiel R de BoerDepartment of Primary and Long-term Care, University of Groningen, University Medical Centre Groningen, PO Box 196, Groningen, 9700 AD, FA21, the Netherlands.
Martin SmalbruggeDepartment of Medicine for Older People, Amsterdam UMC, location Vrije Universiteit Amsterdam, de Boelelaan 1117, Amsterdam, the Netherlands.
Sytse U ZuidemaDepartment of Primary and Long-term Care, University of Groningen, University Medical Centre Groningen, PO Box 196, Groningen, 9700 AD, FA21, the Netherlands.

Funding

Dutch Ministry of Health, Welfare and Sports 324366
6 · The paper itself

Abstract

backgroundPsychotropic drugs are modestly effective and may cause adverse effects. Efforts to reduce inappropriateness and increase usage of psychosocial interventions often suffer from suboptimal implementation. The purpose of this study was to evaluate effectiveness of an innovative study using implementation promoting elements in nursing home residents with dementia and neuropsychiatric symptoms.

methodsA multicenter cluster randomized controlled trial with a special case of a stepped-wedge design with two arms and one stap was designed. The intervention comprised participatory action research, tailored information provision and external coaching, leading to the implementation of tailored action and implementation plans. The primary outcome was inappropriateness of psychotropic drug use (Appropriate Psychotropic Drug Use in Dementia [APID] index) and the secondary outcome was percentage of psychotropic drug use at baseline, 8 months, and 16 months. Homes were allocated to start with usual care or the intervention. After 8 months, the control group crossed over to receive the intervention. The other homes continued the intervention to 16 months. Patients were eligible if they were diagnosed with dementia, had a life expectancy of at least 3 months, and resided in psychogeriatric units.

resultsAn adjusted multilevel model revealed no effect on the APID index sum score at 8 months (0.564; 95% confidence interval [CI], -2.449-3.577; p = 0.71) or 16 months (2.165; 95% CI, -1.113-5.443; p = 0.20). An adjusted generalized estimation equation (GEE) model showed an effect at 16 months for percentage of use (OR 0.654; 95% CI, 0.481-0.889; p = 0.007). Adjusted GEE models showed an effect especially at 16 months for anxiolytics (OR 0.573; 95% CI, 0.382-0.859; p = 0.007) and antidepressants (OR 0.678; 95% CI, 0.475-0.968; p = 0.033).

conclusionsNo reduction of inappropriateness was found although overall usage was reduced. Professionals focused on implementing alternatives to compensate for usage, rather than prescribing quality. Future studies may focus on changing physicians' prescribing behaviors in combination with multicomponent and multidisciplinary psychosocial alternatives.

trial registrationNetherlands Trial Registry (NTR5872) on 27/05/2016, https://onderzoekmetmensen.nl/nl/node/26060/pdf .

Indexed as

DementiaHomes for the AgedInappropriate PrescribingNursing HomesPsychotropic DrugsAgedAged, 80 and overCluster AnalysisCross-Over StudiesFemaleHumansMalePsychotropic DrugsComplex interventionsDementiaNeuropsychiatric symptomsNursing homesPsychotropic drugs

Identifiers

PMID40753407
PMCPMC12318394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.